Report cover image

Ophthalmoscopes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Publisher GlobalData
Published Sep 29, 2023
Length 51 Pages
SKU # GBDT18272478

Description

Ophthalmoscopes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Ophthalmoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Ophthalmoscopes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Ophthalmoscope is a lighted instrument used to examine interior of the eye. These are used to assess the health conditions of the retina and the vitreous humor.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Ophthalmoscopes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmoscopes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmoscopes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

51 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Ophthalmoscopes Overview
4 Products under Development
4.1 Ophthalmoscopes - Pipeline Products by Stage of Development
4.2 Ophthalmoscopes - Pipeline Products by Segment
4.3 Ophthalmoscopes - Pipeline Products by Territory
4.4 Ophthalmoscopes - Pipeline Products by Regulatory Path
4.5 Ophthalmoscopes - Pipeline Products by Estimated Approval Date
5 Ophthalmoscopes - Pipeline Products under Development by Companies
5.1 Ophthalmoscopes Companies - Pipeline Products by Stage of Development
5.2 Ophthalmoscopes – Companies Pipeline Products by Stage of Development
6 Ophthalmoscopes Companies and Product Overview
6.1 Aeon Imaging, LLC Company Overview
6.1.1 Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.2 Beaver-Visitec International Inc Company Overview
6.2.1 Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 Boston Micromachines Corporation Company Overview
6.3.1 Boston Micromachines Corporation Pipeline Products & Ongoing Clinical Trials Overview
6.4 Canon USA Inc Company Overview
6.4.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Case Western Reserve University Company Overview
6.5.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
6.6 Duke University Company Overview
6.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
6.7 Hedgefog Research Inc Company Overview
6.7.1 Hedgefog Research Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Medical University of South Carolina Company Overview
6.8.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
6.9 oDocs Eye Care Ltd Company Overview
6.9.1 oDocs Eye Care Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.1 Oxford University Innovation Ltd Company Overview
6.10.1 Oxford University Innovation Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.11 Retinostics Company Overview
6.11.1 Retinostics Pipeline Products & Ongoing Clinical Trials Overview
6.12 Stellenbosch University Company Overview
6.12.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
6.13 Structured Eye Ltd Company Overview
6.13.1 Structured Eye Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.14 University of Illinois Company Overview
6.14.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
6.15 University of Malaya Company Overview
6.15.1 University of Malaya Pipeline Products & Ongoing Clinical Trials Overview
6.16 Welch Allyn Inc Company Overview
6.16.1 Welch Allyn Inc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Yaoshi (Suzhou) Medical Technology Co Ltd Company Overview
6.17.1 Yaoshi (Suzhou) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Ophthalmoscopes- Recent Developments
7.1 Aug 03, 2023: Juho Himberg has been appointed CEO of Optomed
7.2 May 10, 2023: Optomed Announces Decisions of the Annual General Meeting and Board of Directors
7.3 Apr 25, 2023: OPKO Health to report Q1 2023 financial results on May 3, 2023
7.4 Apr 03, 2023: Optomed Notice Of The Annual General Meeting
7.5 Mar 02, 2023: Optomed Announces Annual Report 2022
7.6 Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
7.7 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23
7.8 Jan 30, 2023: Topcon Announces Consolidated Financial Results for the Third Quarter of FY2022 Ending March 2023
7.9 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
7.1 Oct 28, 2022: Topcon Consolidated Financial Results for the Second Quarter of FY2022 Ending March 2023
7.11 Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Ophthalmoscopes - Pipeline Products by Stage of Development
Table 2: Ophthalmoscopes - Pipeline Products by Segment
Table 3: Ophthalmoscopes - Pipeline Products by Territory
Table 4: Ophthalmoscopes - Pipeline Products by Regulatory Path
Table 5: Ophthalmoscopes - Pipeline Products by Estimated Approval Date
Table 6: Ophthalmoscopes Companies - Pipeline Products by Stage of Development
Table 7: Ophthalmoscopes – Companies Pipeline Products by Stage of Development
Table 8: Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Digital Light Ophthalmoscope (DLO) - Product Status
Table 10: Digital Light Ophthalmoscope (DLO) - Product Description
Table 11: Digital Light Ophthalmoscope Adaptive Optics System - Product Status
Table 12: Digital Light Ophthalmoscope Adaptive Optics System - Product Description
Table 13: Laser Scanning Digital Camera - Product Status
Table 14: Laser Scanning Digital Camera - Product Description
Table 15: Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Leos - Product Status
Table 17: Leos - Product Description
Table 18: Miro - Product Status
Table 19: Miro - Product Description
Table 20: Boston Micromachines Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Next Generation Adaptive Optics Scanning Laser Ophthalmoscope - Product Status
Table 22: Next Generation Adaptive Optics Scanning Laser Ophthalmoscope - Product Description
Table 23: Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) System - Product Status
Table 25: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) System - Product Description
Table 26: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Two-photon Ophthalmoscope - Product Status
Table 28: Two-photon Ophthalmoscope - Product Description
Table 29: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 30: HAOSLO - Product Status
Table 31: HAOSLO - Product Description
Table 32: Hedgefog Research Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Ophthalmic Microendoscope - Product Status
Table 34: Ophthalmic Microendoscope - Product Description
Table 35: Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Retinal Disease Evaluation Device - Product Status
Table 37: Retinal Disease Evaluation Device - Product Description
Table 38: oDocs Eye Care Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 39: visoScope - Product Status
Table 40: visoScope - Product Description
Table 41: Oxford University Innovation Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Adaptive Optics Scanning Laser Ophthalmoscope - Product Status
Table 43: Adaptive Optics Scanning Laser Ophthalmoscope - Product Description
Table 44: Retinostics Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Ultra-high Resolution Scanning Laser Ophthalmoscope - Product Status
Table 46: Ultra-high Resolution Scanning Laser Ophthalmoscope - Product Description
Table 47: Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Smartphone Based Ophthalmoscope - Product Status
Table 49: Smartphone Based Ophthalmoscope - Product Description
Table 50: Structured Eye Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Structured Illumination Ophthalmoscope - Product Status
Table 52: Structured Illumination Ophthalmoscope - Product Description
Table 53: University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Handheld Scanner - Primary Care Imaging - Product Status
Table 55: Handheld Scanner - Primary Care Imaging - Product Description
Table 56: University of Malaya Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Point-Of-Care Teleophthalmoscope - Product Status
Table 58: Point-Of-Care Teleophthalmoscope - Product Description
Table 59: Welch Allyn Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Welch Allyn PanOptic Plus Ophthalmoscope - Product Status
Table 61: Welch Allyn PanOptic Plus Ophthalmoscope - Product Description
Table 62: Yaoshi (Suzhou) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Confocal Laser Scanning Ophthalmoscope - Product Status
Table 64: Confocal Laser Scanning Ophthalmoscope - Product Description
Table 65: Glossary
2.2 List of Figures
Figure 1: Ophthalmoscopes - Pipeline Products by Stage of Development
Figure 2: Ophthalmoscopes - Pipeline Products by Segment
Figure 3: Ophthalmoscopes - Pipeline Products by Territory
Figure 4: Ophthalmoscopes - Pipeline Products by Regulatory Path
Figure 5: Ophthalmoscopes - Pipeline Products by Estimated Approval Date

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us